EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cebulactam A3, a Macrolactam from Marine-Derived Saccharopolyspora sp. PG10, and Its Antibacterial Activity

Chan Kim iD, Thinh T M Bui, Hyeongju Jeong iD, Soohyun Um iD, Kyuho Moon iD

Marine Drugs · 14.06.2026 · 24 (6) · 211

DOI: 10.3390/md24060211 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 14.06.2026. Verfasst von Chan Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrated Drug Development and Natural Products, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Saccharopolyspora, Aquatic Organisms, Lactams, Macrocyclic. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea government, Ministry of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemical analysis of the marine-derived Saccharopolyspora sp. PG10 led to the isolation of a novel macrolactam, cebulactam A3 (1), along with four known congeners, cebulactams A1 and A2 (2 and 3) and shengliangmycins B and D (4 and 5). The structure of 1 was established by high-resolution mass spectrometry (HRMS) and comprehensive nuclear magnetic resonance (NMR) analyses, and its absolute configuration was determined using Mosher’s method. Genome analysis identified a putative biosynthetic gene cluster consistent with a hybrid polyketide pathway. Antimicrobial evaluation revealed that shengliangmycin B exhibited the strongest activity, whereas cebulactam analogs exhibited weaker effects. These findings expand the structural diversity of cebulactam-type macrolactams and provide insights into their stereochemical variation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsSaccharopolysporaAquatic OrganismsLactams, MacrocyclicMicrobial Sensitivity TestsMagnetic Resonance SpectroscopyMultigene FamilyMolecular Structure

Stichwörter der Autor:innen

antibacterial activitymarine sedimentsecondary metabolitestructural elucidation

Substanzen

Anti-Bacterial AgentsLactams, Macrocyclic

Autor:innen und Institutionen

  • Department of Integrated Drug Development and Natural Products, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea.
  • College of Pharmacy and Institute of Integrated Pharmaceutical Sciences, Kyung Hee University, Seoul 02447, Republic of Korea.
  • Department of Forest Products and Biotechnology, Kookmin University, Seoul 02707, Republic of Korea.

ORCID-Profile: Chan Kim, Hyeongju Jeong, Soohyun Um, Kyuho Moon

Förderung

  • Korea government
  • Ministry of Education

Zitieren

APA

Kim, C., Bui, T. T. M., Jeong, H., Um, S., & Moon, K. (2026). Cebulactam A3, a Macrolactam from Marine-Derived Saccharopolyspora sp. PG10, and Its Antibacterial Activity. Marine Drugs, 24(6), 211. https://doi.org/10.3390/md24060211

Vancouver

Kim C, Bui TTM, Jeong H, Um S, Moon K. Cebulactam A3, a Macrolactam from Marine-Derived Saccharopolyspora sp. PG10, and Its Antibacterial Activity. Marine Drugs. 2026;24(6):211. doi:10.3390/md24060211

BibTeX
@article{Kim2026,
  author = {Kim, Chan and Bui, Thinh T M and Jeong, Hyeongju and Um, Soohyun and Moon, Kyuho},
  title = {Cebulactam A3, a Macrolactam from Marine-Derived Saccharopolyspora sp. PG10, and Its Antibacterial Activity},
  journal = {Marine Drugs},
  year = {2026},
  volume = {24},
  number = {6},
  pages = {211},
  doi = {10.3390/md24060211}
}
Kostenlos starten →